Esperion Therapeutics Stock Soars 56% On Acquisition Deal
Summary
Esperion Therapeutics, Inc. (ESPR) shares surged 56.25 percent to $3.1250 on Friday, gaining $1.1250, after the company announced a definitive acquisition agree...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.